Evaluation of Changes in Platelet Level and Influenced Factors in Patients with Thrombocytopenia

Document Type : Original Article (s)


1 Assistant Professor, Department of Anesthesiology, School of Medicine, Isfahan University of Medicine Sciences, Isfahan, Iran

2 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medicine Sciences, Isfahan, Iran


Background: Hemostasis is a hemodynamic process in which the platelet play a major role. Platelet transfusion is one of the effective treatments in patients with thrombocytopenia, which has been increased during the recent decades. There is limited data regard the factors that influence the amount of increase in platelet levels in patients with thrombocytopenia who undergo platelet transfusion.Methods: 35 patients with thrombocytopenia who underwent platelet transfusion in Alzahra hospital, Isfahan, Iran, between the years 2012 and 2014 were enrolled. Platelet levels were measured 1 hour before and 24 hour after platelet transfusion. Changes in platelet levels were evaluated considering demographic and clinical characteristics of patients.Findings: The average platelet count after platelet transfusion was significantly higher than before it (P = 0.001). Gender, splenomegaly, fever, and receiving heparin had significant effect on the change in platelet count (P < 0.050 for all) whereas bleeding had no significant effect (P ≥ 0.050).Conclusion: Variable factors could influence the efficacy of platelet transfusion in patients with thrombocytopenia. Future prospective studies with enough sample sizes are needed in order to warrantee the results.


  1. Lozano M, Cid J. Platelet concentrates: Balancing between efficacy and safety? Presse Med 2016; 45(7-8 Pt 2): e289-e298.
  2. Foster JC, Sappenfield JW, Smith RS, Kiley SP. Initiation and termination of massive transfusion protocols: current strategies and future prospects. Anesth Analg 2017; 125(6): 2045-55.
  3. Webert KE, Alam AQ, Charge SB, Sheffield WP. Platelet utilization: A Canadian Blood Services research and development symposium. Transfus Med Rev 2014; 28(2): 84-97.
  4. Katus MC, Szczepiorkowski ZM, Dumont LJ, Dunbar NM. Safety of platelet transfusion: past, present and future. Vox Sang 2014; 107(2): 103-13.
  5. Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81(5): 1650-7.
  6. Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 2005; 27(4): 592-8.
  7. Cimo PL, Moake JL, Weinger RS, Ben-Menachem YB, Khalil KG. Heparin-induced thrombocytopenia: Association with a platelet aggregating factor and arterial thromboses. Am J Hematol 1979; 6(2): 125-33.
  8. Doughty HA, Murphy MF, Metcalfe P, Rohatiner AZ, Lister TA, Waters AH. Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sang 1994; 66(3): 200-5.
  9. Bishop JF, McGrath K, Wolf MM, Matthews JP, De Luise T, Holdsworth R, et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988; 71(2): 383-7.
  10. Pirzadeh A, Forouzanfar M, Asdaghi Z. Assessment of therapeutic platelet transfusion effectiveness in thrombocytopenic hospitalized patients in hematology unit of Emam Khomeini Hospital, Ardabil [MD Thesis]. Ardabil: Ardabil University of Medical Sciences; 2012. [In Persian].
  11. Arnold DM, Crowther MA, Cook RJ, Sigouin C, Heddle NM, Molnar L, et al. Utilization of platelet transfusions in the intensive care unit: Indications, transfusion triggers, and platelet count responses. Transfusion 2006; 46(8): 1286-91.
  12. Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50(6): 1227-39.
  13. Martin RC, Jarnagin WR, Fong Y, Biernacki P, Blumgart LH, DeMatteo RP. The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: is there a standard for transfusion? J Am Coll Surg 2003; 196(3): 402-9.
  14. Yamazaki S, Takayama T, Kimura Y, Moriguchi M, Higaki T, Nakayama H, et al. Transfusion criteria for fresh frozen plasma in liver resection: a 3 + 3 cohort expansion study. Arch Surg 2011; 146(11): 1293-9.
  15. Ejaz A, Frank SM, Spolverato G, Kim Y, Pawlik TM. Defining transfusion triggers and utilization of fresh frozen plasma and platelets among patients undergoing hepatopancreaticobiliary and colorectal surgery. Ann Surg 2015; 262(6): 1079-85.
  16. Alikiaii B, Hashemi ST, Manteghi F. Evaluation of platelet elevation after injection in patients over 40 years of age admitted hospital; a retrospective study. J Isfahan Med Sch 2007; 35(451): 1438-43. [In Persian].
  17. O'Shaughnessy DF, Atterbury C, Bolton MP, Murphy M, Thomas D, Yates S, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126(1): 11-28.
Volume 35, Issue 464 - Serial Number 464
November and December 2018
Pages 1969-1973
  • Receive Date: 10 November 2017
  • Revise Date: 04 October 2023
  • Accept Date: 06 April 2022
  • First Publish Date: 06 April 2022